top of page

The only pharma intelligence company covering the global market 

See the whole picture with PHARMALERT
VISION

Pharmalert monitors regulatory approvals globally 

Keeping you up to date on the market reach of your molecules of interest, whether you are a drug developer on the watch for first-mover generics and biosimilars or you want to verify that your biopharma investment targets are capitalizing on the full potential of their products.

We do not rely on companies' press releases. We provide you with comprehensive data on when and where your medicines of interest gain approval or lose market dominance to competitors.

PHARMALERT

Simple subscribing process

HIRING OUR SERVICE

SEARCH YOUR MOLECULE

Go to our SIGN UP page to search through our portfolio by brand name, generic name or developer, or CONTACT US to request unlisted molecules

buscar_editada.jpg

SELECT PERIOD OF TIME

Finally, choose a period of either 6 months or 1 year of e-mail alerts for each molecule, add to your cart and pay online

Purchasing options for e-mail alerts

WHY PHARMALERT

We have a background of 10+ years in the biopharmaceutical sector 

And 5+ years’ experience monitoring the developments in the global healthcare industry, including the regulatory process necessary for a drug to enter a market and generate profit.

We know what to look for and we don’t stop watching.

Línea de producción de vacunas

OUR SCOPE AT A GLANCE

Some of the companies we work with